amino semaglutide GLP-1 Receptor Agonist Research Reference Glucagon‐like peptide‐1 and semaglutide. (a)

If youre overweight or obese, you may be a candidate for GLP-1 drug therapy

Youll need a referral from your GP to a specialist weight management service

This is particularly interesting as next-generation multi-receptor agonists that incorporate glucagon receptor agonism have shown tremendous promise for weight loss and glycemic control, including triagonists for the GLP-1R, GIPR and GCGR 44,45

We know that weight loss is not just about a number on a scale

Furthermore, the multifaceted manifestations of bipolar disorder underscore the necessity to explore diverse therapeutic options

If youre considering Semaglutide or Tirzepatide, your first step is a quick phone call with one of our knowledgeable staff members